Vivo Opportunity Fund Holdings, L.P. - Jun 30, 2025 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value (CDTX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
CDTX
Shares outstanding
25.6M shares
Disclosed Ownership
1.18M shares
Ownership
4.6%
Form type
SCHEDULE 13G/A
Date filed
8/12/2025, 08:50 PM
Date of event
Jun 30, 2025
Previous filing
May 15, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 4.6% 1.18M 1.18M 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity, LLC 4.6% 1.18M 1.18M 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.5% 136K 136K 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman, LLC 0.5% 136K 136K 0 /s/ Kevin Dai Kevin Dai/Managing Member